ReviewFrontiers in immunology2026
The 3D landscape of infection: spatial organization and
Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Microbial infections rarely consist of free-floating cells. Instead, pathogens and immune cells are typically organized into complex three-dimensional (3D) structures, including biofilms, abscesses, and granulomas, which can serve to constrain pathogen dissemination. At the same time, these architectures create protective microenvironments that promote microbial persistence, immune evasion, and increased resistance to antimicrobial therapies. A mechanistic understanding of how spatially organized tissue structures and local microenvironmental cues shape host-pathogen dynamics may open new avenues for therapeutic interventions, for example by improving targeted drug delivery, enhancing antibiotic penetration, or disrupting protective microbial niches. In this review, we summarize emerging insights into the 3D landscape of infections and highlight advances in experimental platforms that more faithfully recapitulate tissue architecture, including 3D cell culture systems, bioprinted tissue, organoids, and organ-on-chip technologies. Finally, we discuss how integrating spatial parameters into infection models reshapes our understanding of pathogenesis and opens new conceptual and therapeutic avenues for combating infections.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.